CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Experimental pill promises new hope for deadly pancreatic cancer
Posted
June 1, 2026
Views
1,643
Likes
34
Comments
1
Engagement
June 1, 2026
1,643
34
1
2.13%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:15Now PlayingCNBC's Angelica Peebles reports from the American Society of Clinical Oncology, or ASCO, about an experimental pill that promises new hope for pancreatic cancer patients.
The drug is called daraxonrasib, and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
